Keyphrases
Randomized Controlled Trial
100%
Etonogestrel Implant
100%
Ulipristal Acetate
100%
Unscheduled Bleeding
100%
Bleeding
63%
Placebo
36%
Placebo Groups
18%
Vaginal Progesterone
18%
Demographic Characteristics
9%
Randomized Placebo-controlled Trial
9%
Between-group
9%
U.S. Food
9%
Single Center
9%
Dropout
9%
Ovulation
9%
Bleeding Episodes
9%
Diary
9%
Participant Satisfaction
9%
Ovulatory
9%
Bleeding Profile
9%
Automated Text Messaging
9%
Medicine and Dentistry
Bleeding
100%
Randomized Controlled Trial
100%
Etonogestrel
100%
Ulipristal
100%
Placebo
63%
Progesterone
18%
Implant
9%
Effect Size
9%
Demography
9%
Ovulation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
100%
Randomized Controlled Trial
100%
Ulipristal
100%
Etonogestrel
100%
Placebo
63%
Progesterone
18%
Implant
9%